Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
The Medtronic CoreValve Evolute on display at ACC 2022. The valve performed better than surgical valved in terms on structural deterioration. #ACC22

Redo TAVR appears feasible for most patients with supra-annular, self-expanding Evolut valves

Researchers evaluated data from more than 200 patients who underwent redo TAVR, noting that women and patients with a higher BMI faced a higher risk of coronary flow compromise.

ACS and revascularization after TAVR: New data on a high-risk scenario

“It is vital to identify patients who are at a high risk for ACS after TAVR for potential treatment beforehand,” according a new analysis published in the American Journal of Cardiology.

The variable fluorescence attenuation of blood has been a hindrance to near-infrared fluorescence (NIRF) measurements in cardiovascular imaging. Fortunately, researchers have devised an innovative correction method in which the guidewire (GW) is coated with the fluorescent agent (ICG) and used as a reference standard in each frame, leading to a much higher accuracy. Credit: Rauschendorfer et al., doi 10.1117/1.JBO.28.4.046001

New technique improves accuracy of near-infrared fluorescence imaging

NIRF imaging could help interventional cardiologists personalize care in the cath lab, but a key engineering issue needed to be solved first.

Thumbnail

Clopidogrel linked to better long-term outcomes than aspirin in PCI patients with and without diabetes

Clopidogrel is especially effective at limiting major adverse cardiovascular events among PCI patients with diabetes, researchers found. 

The LuX-Valve Plus transcatheter tricuspid valve replacement (TTVR) device

Cardiologists make history, perform TTVR with new-look valve for first time in U.S.

The new valve was placed inside the damaged valve via a catheter that is inserted through a small incision in the patient's neck. 

SCAI blasts Medicare payment cuts to cardiology, asks members to take action

The group hopes its members can increase congressional support of a new bill introduced in the House. 

Sunil Rao, MD, FSCAI, 2022-23 President of the Society of Cardiovascular Angiography and Interventions (SCAI), and director of interventional cardiology NYU Langone, explains efforts by SCAI to address the shift in interventional procedures from hospitals to less expensive ambulatory surgical centers (ASC).

Maintaining quality is key as more cardiac procedures migrate to outpatient ASCs

SCAI President Sunil Rao, MD, discussed the group's efforts to address the shift in interventional procedures from hospitals to less expensive ambulatory surgical centers.

Eric Secemsky, MD, FACC, FAHA, FSCAI, FSVM, director of vascular intervention at Beth Israel Deaconess Medical Center, Boston, Massachusetts, presented the results of a real-world evidence study of data for over 1 million U.S. Medicare patients to evaluate trends in the use of, and outcomes associated with, intravascular imaging during percutaneous coronary interventions (PCI). #IVUS

Intravascular imaging-guided PCI boosts outcomes, but utilization remains low

Eric Secemsky, MD, told Cardiovascular Business that a lack of training is one of the biggest factors limiting the use of intravascular imaging-guided PCI among interventional cardiologists. 

Displaying 417 - 424 of 975
Design by Adaptive Theme